» Articles » PMID: 35773506

Immune-Mediated Neonatal Thrombocytopenia

Overview
Journal Neoreviews
Date 2022 Jun 30
PMID 35773506
Authors
Affiliations
Soon will be listed here.
Abstract

Immune-mediated thrombocytopenia in neonates is caused by the transplacental passage of maternally derived antiplatelet antibodies. The 2 most common causes include neonatal alloimmune thrombocytopenia, which leads to significant thrombocytopenia and risk of intracranial hemorrhage, and autoimmune thrombocytopenia, which is generally less severe. No specific guidelines for prenatal management exist for either disease; however, intravenous immune globulin treatments and systemic steroids for women with at-risk pregnancies can be useful in both diseases. In this review, we discuss the current literature and management strategies for both pregnant women and newborns with immune-mediated thrombocytopenia.

Citing Articles

Autoimmune Thrombocytopenia in Pregnancy: Insights from an Uncommon Case Presentation and Mini-Review.

Malutan A, Pascu O, Diculescu D, Ciortea R, Blaga L, Nicula R J Clin Med. 2025; 14(3).

PMID: 39941544 PMC: 11818785. DOI: 10.3390/jcm14030872.


Acinetobacter baumannii Early-Onset Sepsis After Home Delivery Into Toilet Water.

Sousa P, Sousa B, Calheiros-Trigo F, Martins M, Paz-Dias C Cureus. 2023; 15(9):e45951.

PMID: 37885560 PMC: 10599798. DOI: 10.7759/cureus.45951.